PI3K/Akt and Stem Cells in two breast cancer cell lines.

被引：0
|
作者：
Cerliani, Juan
Gargini, Ricardo
Calvo, Juan
Lanari, Claudia
Izquierdo, Marta
机构：
[1] IByME, Buenos Aires, DF, Argentina
[2] UAM, CBM, Madrid, Spain
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2019
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mechanisms of acquired resistance to the PI3K inhibitors in colorectal cancer cell lines.
    Edgar, Kyle A.
    Wagle, Marie-Claire
    Yan, Yibing
    Belvin, Marcia
    Friedman, Lori
    Wallin, Jeffrey
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [2] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [3] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    [J]. Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [4] The impact of PI3K/AKT inhibitor on the radiosensitization of breast cancer cells
    Fu, S
    Zeng, QW
    Sun, Y
    Zhang, Q
    Shao, YH
    Jian, GL
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S93 - S93
  • [5] ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway
    Qu, Yikun
    Hao, Chunfang
    Xu, Jian
    Cheng, Zhuoxin
    Wang, Weiqun
    Liu, Hong
    [J]. MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5036 - 5042
  • [6] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    [J]. CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [7] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    [J]. Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [8] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    [J]. Cancer Biology & Medicine., 2015, 12 (04) - 354
  • [9] Msi1 in maintaining breast cancer stem cell involves the AKT/PI3K pathway
    Nahas, G. R.
    Sinha, G. A.
    Sherman, L. S.
    Walker, N. D.
    Rameshwar, P.
    [J]. CANCER RESEARCH, 2016, 76
  • [10] PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
    Yoon, Changhwan
    Lu, Jun
    Yi, Brendan C.
    Chang, Kevin K.
    Simon, M. Celeste
    Ryeom, Sandra
    Yoon, Sam S.
    [J]. ONCOGENESIS, 2021, 10 (01)
12345